Hospital acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries. In particular in developing countries it poses an enormous negative impact on health delivery costs. The cost may direct (the cost of medicines, bed occupation etc.) or indirect (as patients are deprived of work). According to a WHO study: 55 hospitals of 14 countries in South-East Asia, Europe, the Eastern Mediterranean and Western Pacific revealed that on average 8.7% of hospital patients suffer nosocomial infections. Globally, at least 1 in 4 patients in intensive care will acquire an infection during their stay in hospital. Thus stringent guidelines are being provided to prevent hospital infection and control the same. The WHO and various others regulatory bodies at regional and national level provide guidelines for hospital infection prevention and control. Rising prevalence of nosocomial infection and regulatory guidelines and measures are the driving factor of the global hospital infection prevention and control market.
The report titled “Global Hospital Infection Prevention and Control market - Growth, Share, Opportunities and Competitive Analysis, 2016–2024” offers strategic insights into the overall hospital infection prevention and control market along with the market size and estimates for the duration 2016 to 2024. The said research study covers in-depth analysis of multiple market segments based on type of infection, products and different geographies. The infection type segment studied for analyzing the overall global hospital infection prevention and control market is majorly segmented into pneumonia, urinary tract infection, blood stream infection, surgical site infection, MRSA and others. The product type segment studied for analyzing the global hospital infection prevention and control market is majorly segmented into as infection prevention supplies, infection prevention equipment and infection prevention services.
Geographically, the global hospital infection prevention and control market is studied for the following regional markets:
- North America
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
Market size and forecast for these regional and country level markets are presented in this study for the period 2014-2024. Market growth rates for the forecast period 2016-2024 are also included in this report, considering 2015 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global hospital infection prevention and control market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global hospital infection prevention and control market. This report concludes with company profiles section that highlights major information about the key players engaged in global hospital infection prevention and control market. In-depth competitive environment analysis and historical (2014) market size data are also provided in the report.
